CV Sciences, Inc. (OTC: CVSI)

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic CIK: 0001510964
ROIC (Qtr) -0.20
Total Debt (Qtr) 1.65 Mn
Revenue Growth (1y) (Qtr) -14.86
Add ratio to table...

About

CV Sciences, Inc. specializes in the development, manufacture, and distribution of nutraceuticals and plant-based foods, with a focus on hemp extracts and other natural ingredients. The company operates in the consumer wellness industry, catering to both business-to-business (B2B) and business-to-consumer (B2C) markets. CV Sciences generates revenue through the sale of its branded products, which include hemp extracts and plant-based food items. The company's primary products are sold under the brands +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar...

Read more

Contract with Customer, Sales Channel Breakdown of Revenue (2024)

Peer comparison

Companies in the Drug Manufacturers - Specialty & Generic
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 ZTS Zoetis Inc. 52.41 Bn 19.60 5.54 9.04 Bn
2 TEVA Teva Pharmaceutical Industries Ltd 35.83 Bn 25.23 2.08 16.81 Bn
3 UTHR UNITED THERAPEUTICS Corp 25.40 Bn 19.03 7.98 -
4 NBIX Neurocrine Biosciences Inc 12.96 Bn 27.02 4.53 -
5 HCM HUTCHMED (China) Ltd 12.76 Bn 28.06 23.27 0.09 Bn
6 ELAN Elanco Animal Health Inc 11.22 Bn -48.11 2.38 4.02 Bn
7 ALKS Alkermes plc. 5.52 Bn 22.80 3.74 -
8 LNTH Lantheus Holdings, Inc. 5.51 Bn 23.64 3.57 0.57 Bn